Effects of leucine and fatty acids on muscle health in older adults
Official title: Explore the Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly
Run by Chang Gung Memorial Hospital · NCT06991855 · Data updated 2026-11-12
This study is testing if adding leucine-rich protein and healthy fats to the diets of older adults can help improve their muscle health and strength.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 99 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Linkou District) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | April 10, 2026 |
| Study ends | April 17, 2026 |
| Registry record updated | June 22, 2025 |
| Trial ID | NCT06991855 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 50 and older who exhibit signs of muscle weakness or low muscle mass.
✕Probably not a fit
Patients with allergies to the supplements, or those with serious health conditions such as cancer, heart failure, or neurodegenerative diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates how nutritional supplementation with leucine-rich protein and polyunsaturated fatty acids can improve muscle health in middle-aged and elderly individuals aged 50 and above who are at high risk for sarcopenia. Participants will be divided into two groups receiving either animal-based or plant-based oil supplements. The study aims to assess changes in muscle mass and strength, which are critical for maintaining mobility and overall health in the aging population. By focusing on this demographic, the study addresses a significant public health concern as Taiwan approaches a super-aged society.
Why it matters
Potential benefit: If successful, this study could enhance muscle health and functional capacity in elderly individuals, potentially reducing the risk of sarcopenia-related complications.
How similar studies have gone: Other studies have shown promising results with nutritional supplementation for muscle health in older adults, indicating that this approach has potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 50 years * ASMI \< 7 kg/m2 in men * ASMI \< 5.7 kg/m2 in women * Grip strength \< 28 kg in men * Grip strength \< 18 kg in women * Walk speed \< 1 m/s Exclusion Criteria: * People who are allergic to supplements * cancer * heart failure * kidney disease * autoimmune disease * neurodegenerative disease
Where it's running
-
Chang Gung Memorial Hospital
Linkou District, Taiwan Recruiting
Study contacts
- Study coordinator: Hsiang-Yu Tang, Ph.D.
- Email: tangshyu@cgu.edu.tw
- Phone: +886-3-2118800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Volunteer-led lifestyle program to help sarcopenia in older adults
This program tests a digital, volunteer-supported lifestyle plan to improve muscle health and reduce fall risk in older adults with sarcopenia or frailty.
-
AMC6156 for older adults with sarcopenia
This trial will try once-daily AMC6156 pills or a placebo for 12 weeks to see if they improve strength and mobility in older adults with sarcopenia.
-
Movement-speed biofeedback to improve muscle activation and self-perception in older adults with sarcopenia
This test will see if giving older adults with sarcopenia feedback on how fast they move during leg-press exercises helps preserve movement speed, increase muscle activation, and change motivation and perceived effort.
-
Investigating protein changes in aging and muscle function
This study is trying to see how changes in muscle proteins affect strength and movement in older adults to help improve their recovery and mobility.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.